Depression in medically ill patients

Psychiatric Clinics of North America

Volumn 35, Issue 1, 2012, Pages 231-247

  Rackley, Sandra ^a,b   Bostwick, J Michael ^c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c Mayo Clinic   (United States)

Author keywords

Adjustment disorder; Antidepressant medication; Depression; Differential diagnosis; Medical illness; Psychotherapy

Indexed keywords

AMPHOTERICIN; ANTICONVULSIVE AGENT; ASPARAGINASE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DULOXETINE; ESTROGEN; ETHIONAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC SEDATIVE AGENT; INDOMETACIN; INTERFERON; ISOTRETINOIN; LEUPRORELIN; METHYLDOPA; METOCLOPRAMIDE; METRONIDAZOLE; MIRTAZAPINE; OPIATE; PROCARBAZINE; SEROTONIN UPTAKE INHIBITOR; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

ABDOMINAL PAIN; COGNITIVE THERAPY; DELIRIUM; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; HUMAN; MEDICALLY ILL PATIENT; PATIENT; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; SPIRITUAL CARE; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADJUSTMENT DISORDERS; ANTIDEPRESSIVE AGENTS; ATTITUDE TO HEALTH; DEPRESSION; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; DISEASE; DRUG INTERACTIONS; HOSPITALIZATION; HUMANS; PHENOTYPE; PSYCHOTHERAPY; SPIRITUALITY;

EID: 84857393497     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2011.11.001     Document Type: Review

References (76)

1. Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, American Psychiatric Association, American Psychiatric Publishing, Washington, DC. 4th edition.
2. Lloyd-Williams M., Dennis M., Taylor F. A prospective study to compare three depression screening tools in patients who are terminally ill. Gen Hosp Psychiatry 2004, 26(5):384-389.
3. Nease D.E., Maloin J.M. Depression screening: a practical strategy. J Fam Pract 2003, 52(2):118-124.
4. Chochinov H.M., Wilson K.G., Enns M., et al. "Are you depressed?" Screening for depression in the terminally ill. Am J Psychiatry 1997, 154(5):674-676.
5. Griffith J.L., Gaby L. Brief psychotherapy at the bedside: countering demoralization from medical illness. Psychosomatics 2005, 46(2):109-116.
6. Sansone R.A., Sansone L.A. Demoralization in patients with medical illness. Psychiatry (Edgmont) 2010, 7(8):42-45.
7. Breitbart W., Rosenfeld B., Pessin H., et al. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA 2000, 284(22):2907-2911.
8. Rosenfeld B., Breitbart W., Gibson C., et al. Desire for hastened death among patients with advanced AIDS. Psychosomatics 2006, 47(6):504-512.
9. Rosenfeld B., Gibson C., Kramer M., et al. Hopelessness and terminal illness: the construct of hopelessness in patients with advanced AIDS. Palliat Support Care 2004, 2(1):43-53.
10. Strain J.J., Smith G.C., Hammer J.S., et al. Adjustment disorder: a multisite study of its utilization and interventions in the consultation-liaison psychiatry setting. Gen Hosp Psychiatry 1998, 20(3):139-149.
11. Fang J., Cheng Q. Etiological mechanisms of post-stroke depression: a review. Neurol Res 2009, 31(9):904-909.
12. Maes M., Yirmyia R., Noraberg J., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis 2009, 24(1):27-53.
13. Hoen P.W., Whooley M.A., Martens E.J., et al. Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol 2010, 56(11):838-844.
14. Pan A., Okereke O.I., Sun Q., et al. Depression and incident stroke in women. Stroke 2011, Accessed August 14, 2011. http://www.ncbi.nlm.nih.gov/pubmed/21836097.
15. Duivis H.E., de Jonge P., Penninx B.W., et al. Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry 2011, 168(9):913-920.
16. Krousel-Wood M., Islam T., Muntner P., et al. Association of depression with antihypertensive medication adherence in older adults: cross-sectional and longitudinal findings from CoSMO. Ann Behav Med 2010, 40(3):248-257.
17. Gonzalez J.S., Batchelder A.W., Psaros C., et al. Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. JAIDS 2011, 58(2):181.
18. Hood K.K., Rausch J.R., Dolan L.M. Depressive symptoms predict change in glycemic control in adolescents with type 1 diabetes: rates, magnitude, and moderators of change. Pediatr Diabetes 2011, Accessed September 20, 2011. http://www.ncbi.nlm.nih.gov/pubmed/21564454.
19. Bremne J.D., Vermetten E. Stress and development: behavioral and biological consequences. Dev Psychopathol 2001, 13(3):473-489.
20. Whooley M.A., de Jonge P., Vittinghoff E., et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA 2008, 300(20):2379-2388.
21. Serrano C.V., Setani K.T., Sakamoto E., et al. Association between depression and development of coronary artery disease: pathophysiologic and diagnostic implications. Vasc Health Risk Manag 2011, 7:159-164.
22. Loftis J.M., Socherman R.E., Howell C.D., et al. Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C. Neurosci Lett 2004, 365(2):87-91.
23. Hartmann N., Boehner M., Groenen F., et al. Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. Depress Anxiety 2010, 27(12):1111-1116.
24. Simon N.M., Smoller J.W., McNamara K.L., et al. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 2006, 60(5):432-435.
25. Katon W., Schulberg H. Epidemiology of depression in primary care. Gen Hosp Psychiatry 1992, 14(4):237-247.
26. Maletic V., Raison C.L. Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci 2009, 14:5291-5338.
27. Kleinman A. Culture and depression. N Engl J Med 2004, 351(10):951-953.
28. Kirmayer L.J. Cultural variations in the clinical presentation of depression and anxiety: implications for diagnosis and treatment. J Clin Psychiatry 2001, 62(Suppl 13):22-28. [discussion: 29-30].
29. Nandagopal J.J., DelBello M.P. Selegiline transdermal system: a novel treatment option for major depressive disorder. Expert Opin Pharmacother 2009, 10(10):1665-1673.
30. Komossa K., Depping A.M., Gaudchau A., et al. Second-generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database Syst Rev 2010, (12). CD008121.
31. Hardy S.E. Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. Am J Geriatr Pharmacother 2009, 7(1):34-59.
32. Dalal S., Melzack R. Potentiation of opioid analgesia by psychostimulant drugs: a review. J Pain Symptom Manage 1998, 16(4):245-253.
33. Rasmussen K.G., Rummans T.A., Richardson J.W. Electroconvulsive therapy in the medically ill. Psychiatr Clin North Am 2002, 25(1):177-193.
34. Schak K.M., Mueller P.S., Barnes R.D., et al. The safety of ECT in patients with chronic obstructive pulmonary disease. Psychosomatics 2008, 49(3):208-211.
35. Rasmussen K.G., Keegan B.M. Electroconvulsive therapy in patients with multiple sclerosis. J ECT 2007, 23(3):179-180.
36. Mueller P.S., Albin S.M., Barnes R.D., et al. Safety of electroconvulsive therapy in patients with unrepaired abdominal aortic aneurysm: report of 8 patients. J ECT 2009, 25(3):165-169.
37. Rasmussen K.G., Richardson J.W. Electroconvulsive therapy in palliative care. Am J Hosp Palliat Care 2011, 28(5):375-377.
38. Fregni F., Pascual-Leone A. Transcranial magnetic stimulation for the treatment of depression in neurologic disorders. Curr Psychiatry Rep 2005, 7(5):381-390.
39. Kim D.R., Epperson N., Paré E., et al. An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. J Womens Health (Larchmt) 2011, 20(2):255-261.
40. Levy M.L., Levy K.M., Hoff D., et al. Vagus nerve stimulation therapy in patients with autism spectrum disorder and intractable epilepsy: results from the vagus nerve stimulation therapy patient outcome registry. J Neurosurg Pediatr 2010, 5(6):595-602.
41. Noe K.H., Locke D.E.C., Sirven J.I. Treatment of depression in patients with epilepsy. Curr Treat Options Neurol 2011, 13(4):371-379.
42. Strutt A.M., Simpson R., Jankovic J., et al. Changes in cognitive-emotional and physiological symptoms of depression following STN-DBS for the treatment of Parkinson's disease. Eur J Neurol 2011, Accessed October 16, 2011. http://www.ncbi.nlm.nih.gov/pubmed/21668586.
43. Leppert W. CYP2D6 in the metabolism of opioids for mild to moderate pain. Pharmacology 2011, 87(5-6):274-285.
44. Stearns V. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. Cancer Spectrum Knowl Environ 2003, 95:1758-1764.
45. Sideras K., Ingle J.N., Ames M.M., et al. Coprescription of tamoxifen and medications that inhibit CYP2D6. J Clin Oncol 2010, 28(16):2768-2776.
46. Sola C.L., Bostwick J.M., Hart D.A., et al. Anticipating potential linezolid-SSRI interactions in the general hospital setting: an MAOI in disguise. Mayo Clin Proc 2006, 81(3):330-334.
47. Marcucci C., Sandson N.B., Dunlap J.A. Linezolid-bupropion interaction as possible etiology of severe intermittent intraoperative hypertension?. Anesthesiology 2004, 101(6):1487-1488.
48. DiazGranados N., Ibrahim L.A., Brutsche N.E., et al. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-d-aspartate antagonist in patients with treatment-resistant major depressive disorder. J Clin Psychiatry 2010, 71(12):1605-1611.
49. Ibrahim L., Diazgranados N., Luckenbaugh D.A., et al. Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35(4):1155-1159.
50. Larkin G.L., Beautrais A.L. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Neuropsychopharmacol 2011, 14(8):1127-1131.
51. Kudoh A., Takahira Y., Katagai H., et al. Small-dose ketamine improves the postoperative state of depressed patients. Anesth Analg 2002, 95(1):114-118.
52. Cohen S.P., Liao W., Gupta A., et al. Ketamine in pain management. Adv Psychosom Med 2011, 30:139-161.
53. Stefanczyk-Sapieha L., Oneschuk D., Demas M. Intravenous ketamine "burst" for refractory depression in a patient with advanced cancer. J Palliat Med 2008, 11(9):1268-1271.
54. Grob C.S., Danforth A.L., Chopra G.S., et al. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Arch Gen Psychiatry 2011, 68(1):71-78.
55. Pao M., Ballard E.D., Rosenstein D.L. Growing up in the hospital. JAMA 2007, 297(24):2752-2755.
56. Poleshuck E.L., Talbot N.E., Zlotnick C., et al. Interpersonal psychotherapy for women with comorbid depression and chronic pain. J Nerv Ment Dis 2010, 198(8):597-600.
57. Dobkin R.D., Menza M., Bienfait K.L. CBT for the treatment of depression in Parkinson's disease: a promising nonpharmacological approach. Expert Rev Neurother 2008, 8(1):27-35.
58. Hopko D.R., Bell J.L., Armento M., et al. Cognitive-behavior therapy for depressed cancer patients in a medical care setting. Behav Ther 2008, 39(2):126-136.
59. O'Hea E., Houseman J., Bedek K., et al. The use of cognitive behavioral therapy in the treatment of depression for individuals with CHF. Heart Fail Rev 2009, 14(1):13-20.
60. Chochinov H.M., Kristjanson L.J., Breitbart W., et al. Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: a randomised controlled trial. Lancet Oncol 2011, 12(8):753-762.
61. Breitbart W., Gibson C., Poppito S.R., et al. Psychotherapeutic interventions at the end of life: a focus on meaning and spirituality. Can J Psychiatry 2004, 49(6):366-372.
62. Schlozman S.C. An approach to the psychosocial treatment of the medically ill patient. Med Clin North Am 2010, 94(6):1161-1167. x.
63. Kissane D.W., Clarke D.M., Street A.F. Demoralization syndrome-a relevant psychiatric diagnosis for palliative care. J Palliat Care 2001, 17(1):12-21.
64. Viederman M. The psychodynamic life narrative: a psychotherapeutic intervention useful in crisis situations. Psychiatry 1983, 46(3):236-246.
65. Spiegel D., Bloom J.R., Kraemer H.C., et al. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989, 2(8668):888-891.
66. Edwards A.G., Hulbert-Williams N., Neal R.D. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev 2008, (3). CD004253.
67. Asarnow J.R., Jaycox L.H., Anderson M. Depression among youth in primary care models for delivering mental health services. Child Adolesc Psychiatr Clin North Am 2002, 11(3):477-497. viii.
68. Pyne J.M., Fortney J.C., Curran G.M., et al. Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Arch Intern Med 2011, 171(1):23-31.
69. Katon W., Unützer J., Wells K., et al. Collaborative depression care: history, evolution and ways to enhance dissemination and sustainability. Gen Hosp Psychiatry 2010, 32(5):456-464.
70. Gilbody S., Bower P., Fletcher J., et al. Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 2006, 166(21):2314-2321.
71. Mueller P.S., Plevak D.J., Rummans T.A. Religious involvement, spirituality, and medicine: implications for clinical practice. Mayo Clin Proc 2001, 76(12):1225-1235.
72. Koenig H.G., George L.K., Titus P. Religion, spirituality, and health in medically ill hospitalized older patients. J Am Geriatr Soc 2004, 52(4):554-562.
73. Nelson C.J., Rosenfeld B.J., Breitbart W., et al. Spirituality, religion, and depression in the terminally ill. Psychosomatics 2002, 43(3):213.
74. Ai A.L., Ladd K.L., Peterson C., et al. Long-term adjustment after surviving open heart surgery: the effect of using prayer for coping replicated in a prospective design. Gerontologist 2010, 50(6):798-809.
75. FICA Spiritual History Tool The George Washington Institute for Spirituality and Health (GWish), Accessed September 21, 2011. http://www.gwumc.edu/gwish/clinical/fica.cfm.
76. Griffith J.L. Religion that heals, religion that harms: a guide for clinical practice 2010, Guilford Press, New York. 1st edition.